🔴 Pacific Biosciences is trading 5.29% down today after August 5 revenue miss and guidance cut

Pacific Biosciences is trading at $1.12 (-5.29%), with recent selling pressure following its August 5 earnings report.

• The report showed a revenue miss, reduced 2026 guidance, and delayed breakeven expectations.
• No fresh company-specific announcement clearly explains the August 10 decline.
• Broader markets are only modestly lower, so macro sentiment does not clearly explain this move.